Assessing CVD Risk

Utilizing PCSK9 Inhibitors: Who? When? How Long?

Utilizing PCSK9 Inhibitors: Who? When? How Long?

Elevated LDL-C levels contribute to enhanced cardiovascular risk. Despite …

Expiration Date: 11/20/2017

Max Credits: 0

View Activity

Cardiovascular Risk: Assessment and Risk Reduction

Cardiovascular Risk: Assessment and Risk Reduction

Even when using intensive statin monotherapy, many patients fail to achiev…

Expiration Date: 9/20/2019

Max Credits: 0

View Activity

Risk Reduction in Patients with Complex Dyslipidemia

Risk Reduction in Patients with Complex Dyslipidemia

Dr. Brown discusses incorporating therapeutic regimens that may reduce res…

Expiration Date: 2/23/2017

Max Credits: 0

View Activity

IMPROVE-IT: Ezetimibe Added to Statin Therapy After Acute Coronary Syndromes – A Critical Appraisal

IMPROVE-IT: Ezetimibe Added to Statin Therapy After Acute Coronary Syndromes – A Critical Appraisal

Dr. Cannon assesses the impact of the IMPROVE-IT clinical trial and how it…

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

Progress Toward a Consensus on Cardiovascular Risk Reduction

Progress Toward a Consensus on Cardiovascular Risk Reduction

Dr. Wright assesses the impact of LDL-C reduction in patients with complex…

Expiration Date: 2/23/2017

Max Credits: 0

View Activity

Hypertriglyceridemia: A Clinical, Pathophysiological, and Personal Perspective

Hypertriglyceridemia: A Clinical, Pathophysiological, and Personal Perspective

Dr. Sniderman explains the etiology and pathophysiology of hypertriglyceri…

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

Hypertriglyceridemia and Pancreatitis

Hypertriglyceridemia and Pancreatitis

This CME Activity assesses the clinical significance and implications of s…

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

Secondary Hypertriglyceridemia – Medications, Diet and Lifestyle Interventions, Diseases

Secondary Hypertriglyceridemia – Medications, Diet and Lifestyle Interventions, Diseases

This CME activity covers secondary causes of hypertriglyceridemia, evidenc…

Expiration Date: 1/11/2019

Max Credits: 0

View Activity

Hypertriglyceridemia – The Role of Triglyceride-Enriched Lipoproteins in Atherogenesis

Hypertriglyceridemia – The Role of Triglyceride-Enriched Lipoproteins in Atherogenesis

This CME Activity reviews the etiology and pathophysiology of hypertriglyc…

Expiration Date: 2/28/2017

Max Credits: 0

View Activity